Migraine Clinical Trials in New York

Showing 41-60 of 72 trials

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

NCT01775735

The primary objective of this study is to evaluate the safety and efficacy of occipital nerve stimulation (ONS) using the Boston Scientific Corporation (BSC) Precision™ System in the management of intractable chronic migraine, when used in conjunction with anti-migraine medications.

Migraine Disorders

Boston Scientific Corporation28 participantsStarted Apr 2013

Valencia, California, United States • Chicago, Illinois, United States • Chicago, Illinois, United States +7 more locations

COMPLETEDPHASE3< 1 mile

Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents

NCT00488514

This study was designed to determine long-term safety of TREXIMET (sumatriptan/naproxen sodium) in adolescents for the acute treatment of migraine.

Migraine Disorders

GlaxoSmithKline656 participantsStarted Jul 2007

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Jonesboro, Arkansas, United States +74 more locations

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents

Migraine Trials in Other Cities

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

Trial of Comprehensive Migraine Intervention

Metoclopramide for Post-Traumatic Headache. A Pilot Study

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

Zomig - Treatment of Acute Migraine Headache in Adolescents

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

Study in Participants With Acute Migraines Headaches

Staccato Loxapine in Migraine (Out Patient)

A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine

A Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

ESCAPE Migraine Trial

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura

Topical Bimatoprost in the Treatment of Migraine

Other Conditions in New York